Quest Diagnostics Ownership
| DGX Stock | USD 166.45 0.46 0.28% |
Shares in Circulation | First Issued 1996-09-30 | Previous Quarter 113 M | Current Value 113 M | Avarage Shares Outstanding 158.1 M | Quarterly Volatility 33 M |
Quest Stock Ownership Analysis
About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 61.87. The company has Price/Earnings To Growth (PEG) ratio of 1.48. Quest Diagnostics recorded earning per share (EPS) of 7.91. The entity last dividend was issued on the 7th of July 2025. The firm had 2:1 split on the 21st of June 2005. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. To learn more about Quest Diagnostics Incorporated call Stephen Rusckowski at 973 520 2700 or check out https://www.questdiagnostics.com.Besides selling stocks to institutional investors, Quest Diagnostics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Quest Diagnostics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Quest Diagnostics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Quest Diagnostics Quarterly Liabilities And Stockholders Equity |
|
Quest Diagnostics Insider Trades History
Less than 1% of Quest Diagnostics Incorporated are currently held by insiders. Unlike Quest Diagnostics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Quest Diagnostics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Quest Diagnostics' insider trades
Quest Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Quest Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest Diagnostics Incorporated backward and forwards among themselves. Quest Diagnostics' institutional investor refers to the entity that pools money to purchase Quest Diagnostics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.8 M | Wells Fargo & Co | 2025-03-31 | 1.8 M | Wellington Management Company Llp | 2025-03-31 | 1.8 M | Amvescap Plc. | 2025-03-31 | 1.3 M | Norges Bank | 2024-12-31 | 1.3 M | Nordea Investment Mgmt Bank Demark A/s | 2025-03-31 | 1.3 M | Fiduciary Management, Inc. Of Milwaukee | 2025-03-31 | 1.3 M | American Century Companies Inc | 2025-03-31 | 1.2 M | Alliancebernstein L.p. | 2025-03-31 | 1.2 M | Vanguard Group Inc | 2025-03-31 | 13.9 M | Blackrock Inc | 2025-03-31 | 10.1 M |
Quest Diagnostics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Quest Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Delaney Mark E over three months ago Acquisition by Delaney Mark E of tradable shares of Quest Diagnostics at 158.025 subject to Rule 16b-3 | ||
Michael Prevoznik over six months ago Disposition of 35146 shares by Michael Prevoznik of Quest Diagnostics at 86.63 subject to Rule 16b-3 | ||
Karthik Kuppusamy over six months ago Disposition of 1775 shares by Karthik Kuppusamy of Quest Diagnostics at 156.9156 subject to Rule 16b-3 | ||
Michael Deppe over six months ago Disposition of tradable shares by Michael Deppe of Quest Diagnostics at 125.02 subject to Rule 16b-3 | ||
Sam Samad over a year ago Disposition of 656 shares by Sam Samad of Quest Diagnostics at 126.36 subject to Rule 16b-3 | ||
John Ziegler over a year ago Sale by John Ziegler of 1953 shares of Quest Diagnostics |
Quest Diagnostics' latest congressional trading
Congressional trading in companies like Quest Diagnostics, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Quest Diagnostics by those in governmental positions are based on the same information available to the general public.
| 2025-04-11 | Representative Carol Devine Miller | Acquired Under $15K | Verify | ||
| 2024-02-13 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-01-02 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Quest Diagnostics Outstanding Bonds
Quest Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Quest Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Quest bonds can be classified according to their maturity, which is the date when Quest Diagnostics Incorporated has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| QUEST DIAGNOSTICS INC Corp BondUS74834LAZ31 | View | |
| US74834LAY65 Corp BondUS74834LAY65 | View | |
| QUEST DIAGNOSTICS INCORPORATED Corp BondUS74834LBB53 | View | |
| US74834LBA70 Corp BondUS74834LBA70 | View | |
| US74834LBC37 Corp BondUS74834LBC37 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Quest Diagnostics Corporate Filings
F4 | 17th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
ASR | 20th of June 2025 Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
8K | 22nd of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of May 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.